Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

VEGF in brain tumors.

M R Machein1, K H Plate

  • 1Department of Neurosurgery, Neurocenter, Freiburg University Medical School, Germany. machein@nz11.ukl.uni-freiburg.de

Journal of Neuro-Oncology
|March 14, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma.

British journal of cancer·2025
Same author

CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival.

Acta neuropathologica communications·2018
Same author

Progression-free and overall survival in patients with recurrent Glioblastoma multiforme treated with last-line bevacizumab versus bevacizumab/lomustine.

Journal of neuro-oncology·2015
Same author

Loss of FUBP1 expression in gliomas predicts FUBP1 mutation and is associated with oligodendroglial differentiation, IDH1 mutation and 1p/19q loss of heterozygosity.

Neuropathology and applied neurobiology·2013
Same author

Intraindividual comparison of histopathological diagnosis obtained by stereotactic serial biopsy to open surgical resection specimen in patients with intracranial tumours.

Clinical neurology and neurosurgery·2013
Same author

Serum GFAP is a diagnostic marker for glioblastoma multiforme.

Brain : a journal of neurology·2007
Same journal

Real-time confocal imaging for evaluation of dose-dependent effects of gamma knife radiosurgery on U87 glioblastoma cell line.

Journal of neuro-oncology·2026
Same journal

Clinical, surgical, and molecular characteristics and outcomes of adult patients with diffuse midline glioma, H3 K27-altered, treated with surgical resection.

Journal of neuro-oncology·2026
Same journal

Intratumoral serotonin and antidepressants in glioblastoma patients: narrowing the uncertainties.

Journal of neuro-oncology·2026
Same journal

Fractionated stereotactic radiotherapy (fSRT) for symptomatic WHO grade 1 cavernous sinus meningiomas: long-term local control, clinical response, and toxicity outcomes.

Journal of neuro-oncology·2026
Same journal

A label-free nanoplasmonic biosensor for intraoperative discrimination of tumor margins in brain metastases surgery.

Journal of neuro-oncology·2026
Same journal

Endovascular treatment of tumor-related dural sinus stenosis, venous outflow obstruction, and secondary intracranial hypertension: a systematic review of the literature.

Journal of neuro-oncology·2026
See all related articles

Vascular endothelial growth factor (VEGF) drives brain tumor angiogenesis and edema. Targeting VEGF and its receptors offers a promising anti-angiogenesis strategy for brain tumor treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Neuroscience

Background:

  • Vascular endothelial growth factor (VEGF) is crucial for blood vessel formation and permeability.
  • Tumor growth, particularly in the brain, relies heavily on the formation of new blood vessels (angiogenesis).

Purpose of the Study:

  • To describe the molecular and biological properties of VEGF.
  • To present evidence for VEGF-mediated angiogenesis in brain tumors.
  • To discuss anti-angiogenesis strategies targeting the VEGF pathway.

Main Methods:

  • Review of existing literature on VEGF, angiogenesis, and brain tumors.
  • Analysis of VEGF and receptor expression patterns in various brain tumors.
  • Examination of regulatory mechanisms and clinical implications of VEGF in brain tumors.

Related Experiment Videos

Main Results:

  • VEGF plays a significant role in the angiogenesis of brain tumors.
  • VEGF expression and its receptors are altered in different brain tumor types.
  • VEGF contributes to the development of peritumoral edema.

Conclusions:

  • VEGF is a key mediator of angiogenesis in brain tumors.
  • Understanding VEGF's role is critical for developing targeted therapies.
  • Targeting the VEGF pathway represents a viable therapeutic strategy for brain tumors.